Induction of apoptosis by S-allylmercapto-L-cysteine, a biotransformed garlic derivative, on a human gastric cancer cell line

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 765-770

  Lee, Yongkyu ^a  

^a Dongseo University   (South Korea)

Author keywords

Apoptosis; Caspase protein; Cell death; S allylmercapto L cysteine

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; GARLIC EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; S ALLYLMERCAPTOCYSTEINE; UNCLASSIFIED DRUG; CASPASE; CYSTEINE; DRUG DERIVATIVE; S-ALLYLMERCAPTOCYSTEINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL POPULATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIPLOIDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; DRUG TRANSFORMATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STOMACH CANCER; CELL CYCLE; CELL DIFFERENTIATION; CHEMISTRY; DNA FRAGMENTATION; DOSE RESPONSE; GARLIC; GENETICS; IMMUNOBLOTTING; METABOLISM; MITOCHONDRION; NICK END LABELING; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE;

ALLIUM; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASE 9; CASPASES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE; CYTOCHROMES C; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GARLIC; HUMANS; IMMUNOBLOTTING; IN SITU NICK-END LABELING; MITOCHONDRIA; ONCOGENE PROTEIN P21(RAS); PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 47649111994     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.765     Document Type: Article

References (34)

1. Wyllie AH, Kerr JF and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
2. Henkart PA: ICE family proteases: mediators of all apoptotic cell death? Immunity 4: 195-201, 1996.
3. Chinnaiyan AM and Dixit VM: The cell death machine. Curr Biol 6: 555-562, 1996.
4. Liu X, Kim CN, Yang J, Jemmerson R and Wang X: Induction of apoptotic program in cell-free extract: requirement for dATP and cytochrome c. Cell 80: 147-157, 1996.
5. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/ caspase complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
6. Stennicke HR and Salvesen GS: Properties of the caspases. Biochem Biophys Acta 1387: 17-31, 1998.
7. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B and Reed JC: Tumor suppressor p53 is a regulator of Bel-2 and Bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994.
8. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
9. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
10. Tsujimoto Y: Role of Bcl-2 family proteins in apoptosomes or mitochondria? Genes Cells 3: 697-707, 1998.
11. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B and Bomer C: Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499, 1998.
12. Finucanne DM, Bossy-Wetzel E, Waterhouse NJ, Cotter TG and Green DR: Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-XL. J Biol Chem 274: 2225-2233, 1999.
13. Pinto JT, Lapsia S, Shah A, Santiago H and Kim G: Antiproliferative effect of garlic-derived and other allium related compounds. In: Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals: Advances in Experimental Medicine and Biology. American Institute for Cancer Research (eds). Vol. 492, Kluwer Academic/Plenum Publishers, New York, pp83-106, 2000.
14. Wargovich MJ: Diallyl sulfides. A flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 8: 487-489, 1987.
15. Sundaram SG and Milner JA: Impact of organosulfur compounds in garlic on canine mammary tumor cells in culture. Cancer Lett 74: 85-90, 1993.
16. Sakamoto K, Lawson LD and Milner JA: Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. Nutr Cancer 29: 152-156.
17. Weisberger A and Pensky J: Tumor inhibition by a sulfhydryl-blocking agent related to an active principle of garlic (Allium sativum). Cancer Res 18: 1301-1308, 1958.
18. Stipanuk MH, Mondono M, Lee JI, Hu M and Yu AF: Enzymes and metabolites of cysteine metabolism in nonhepatic tissues of rats show little response to changes in dietary protein or sulfur amino acid levels. J Nutr 132: 3369-3378, 2002.
19. Han J, Lawson L, Han GA and Han P: A spectrophotometric method for quantitative determination of allicine and total garlic trisulfinates. Anal Biochem. 225: 157-160, 1995.
20. Shirin H, Pinto JT, Kawabata Y, Soh JW, Delohory T, Moss SF, Murty V, Rivlin RS, Holt PR and Weinstein IB: Antiproliferative effects of s-allylmercaptocysteine on colon cancer cells when tested alone or in combination with sulindac sulfide. Cancer Res 61: 725-731, 2001.
21. Mingjie J, Jaesue C, Jeongnyeo L and Yongkyu L: Induction of apoptosis by ar-turmerone on various cell lines. Int J Mol Med 14: 253-256, 2004.
22. Bhalla RC, Toth KF, Bhatty RA, Thompson LP and Sharma RV: Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. Am J Physiol 272: H1996-H2003, 1997.
23. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocyte. Cell 67: 879-888, 1991.
24. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
25. Kroemer G, Dallaporta B and Resche-Rigon M: The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998.
26. Zamzami N, Brenner C, Marzo I, Susin SA and Kroemer G: Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins. Oncogene 16: 2265-2282, 1998.
27. Ito T, Deng X, Carr B and May WS: Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272: 11671-11673, 1997.
28. Chao DT and Korsmeyer SJ: Bcl-2 family: regulators of cell death. Annu Rev Immunol 16: 395-419, 1998.
29. Hsu YT, Wolter KG and Youle RJ: Cytosol to membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA 94: 3668-3672, 1997.
30. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura Mi, Miller DK, Molineaux SM, Weidner JR and Aunius J: A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774, 1992.
31. Yuan J, Shaham S, Ledoux S, Ellis HM and Horvitz HR: The C. Elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75: 641-652, 1993.
32. Nicholson DW and Thornberry NA: Caspases: killer proteases. Trends Biochem Sci 22: 299-306, 1997.
33. Decaudin D, Marzo I, Brenner C and Kroemer G: Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy. Int J Oncol 12: 141-152, 1998.
34. Earnshaw WC, Martins LM and Kaufmann SH: Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu Rev Biochem 6: 383-424, 1996.